Phase 3Completed

Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients

Evaluation of Effects, Safety, Viral Load and Antibody Level of Functional Food Dietary Supplement Containing Grape Products in Controlled, Randomized Study Using SARSCoV-2 RT-PCR Positive Covid-19 Patients.

Sponsor
RAAS Nutritionals, LLC (Industry)
Enrollment
71 enrolled
Conditions
COVID-19 Respiratory Infection; FLU; Cold; Influenza; Bacterial Pneumonia; COVID-19 Pneumonia
Interventions
Kunamin®; Favipiravir; Enoxaparin; Lansoprazole; Paracetamol; Ceftriaxone/ Clarithromycin; Methylprednisolone
Ages
adults, older adults
Registry
NCT05417997

Full record on ClinicalTrials.gov

From the registry

The primary objective of this study is to determine the safety and efficacy profile of the food supplement (KUNAMIN®) containing grape juice, seed, stem, and bark given to patients treated with the established treatment regimen against novel coronavirus infectious disease (COVID-19) via comparing Kunamin® group versus control group in a clinical trial. In this study, both the therapeutic effect and the safety of the Kunamin® product has been evaluated. The study has been conducted on COVID-19 infected patients. Within the scope of the study, Covid-19 patients consisting of male and female patients are examined to evaluate the therapeutic effect. COVID-19 infected patients are divided into 2 groups and the treatment group received grape food supplements for 15 days in addition to their standard treatment. The other group received only standard therapy. The effects of supplements containing grape products on the COVID-19 infection process of patients are investigated, as indicated in the primary, secondary, and tertiary endpoints. For this purpose, both the observation of routine…

Primary outcomes

  • Decrease in COVID-19, cold and flu viral load to become non detected or negative by Polymerase Chain Reaction.
  • Produce COVID-19 antibodies
  • Decrease in bacteria microbe load to become non detected or reduced.
  • Normalization of fever, respiratory rate, oxygen saturation and alleviation of cough.

History

  1. Registered

  2. Primary completion

  3. Started